M.D.C. Holdings, Inc. (NYSE:MDC) Director David Siegel Sells 29,194 Shares
M.D.C. Holdings, Inc. (NYSE:MDC) Director David Siegel sold 29,194 shares of the company’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $44.90, for a total value of $1,310,810.60. Following the completion of the sale, the director now owns 11,621 shares in the company, valued at approximately $521,782.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Shares of M.D.C. stock opened at $45.69 on Friday. The stock’s 50-day moving average is $36.51 and its 200 day moving average is $34.37. The firm has a market cap of $2.88 billion, a price-to-earnings ratio of 11.13, a PEG ratio of 8.28 and a beta of 1.54. The company has a debt-to-equity ratio of 0.63, a current ratio of 7.53 and a quick ratio of 1.85. M.D.C. Holdings, Inc. has a one year low of $15.75 and a one year high of $48.99.
M.D.C. (NYSE:MDC) last announced its quarterly earnings results on Tuesday, July 28th. The construction company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.48. The business had revenue of $886.80 million for the quarter, compared to analyst estimates of $806.74 million. M.D.C. had a return on equity of 14.75% and a net margin of 7.52%. The company’s quarterly revenue was up 21.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.86 earnings per share. On average, sell-side analysts expect that M.D.C. Holdings, Inc. will post 2.98 EPS for the current fiscal year.
MDC has been the topic of a number of analyst reports. JPMorgan Chase & Co. upped their price target on M.D.C. from $38.50 to $50.00 and gave the company a “neutral” rating in a research report on Wednesday. Zacks Investment Research upgraded M.D.C. from a “sell” rating to a “strong-buy” rating and set a $43.00 price target on the stock in a research report on Tuesday, July 14th. Raymond James cut their target price on M.D.C. from $52.00 to $35.00 and set a “strong-buy” rating on the stock in a research report on Thursday, April 9th. ValuEngine lowered M.D.C. from a “sell” rating to a “strong sell” rating in a research report on Wednesday. Finally, Evercore ISI upgraded M.D.C. from an “in-line” rating to an “outperform” rating and set a $61.00 target price on the stock in a research report on Wednesday. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, two have assigned a buy rating and two have given a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $43.33.
A number of large investors have recently made changes to their positions in MDC. Harel Insurance Investments & Financial Services Ltd. bought a new position in M.D.C. in the second quarter worth approximately $27,000. Mutual of America Capital Management LLC boosted its holdings in M.D.C. by 20.3% in the first quarter. Mutual of America Capital Management LLC now owns 2,145 shares of the construction company’s stock worth $50,000 after acquiring an additional 362 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its holdings in M.D.C. by 29.4% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 2,515 shares of the construction company’s stock worth $58,000 after acquiring an additional 572 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of M.D.C. by 35.9% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,930 shares of the construction company’s stock worth $91,000 after purchasing an additional 1,038 shares during the last quarter. Finally, Ladenburg Thalmann Financial Services Inc. raised its stake in shares of M.D.C. by 120.0% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,106 shares of the construction company’s stock worth $120,000 after purchasing an additional 1,694 shares during the last quarter. Institutional investors and hedge funds own 75.71% of the company’s stock.
M.D.C. Company Profile
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
Featured Article: Investing in Growth Stocks
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.